cancer science institute of singapore
Sox4 Oncogene Potential Target In Acute Myeloid Leukemia
The Sox4 oncogene may be a potential therapeutic target in the treatment of acute myeloid leukemia.
Potential New Treatments For Leukemia
Two international research teams have identified potential new treatments for a particular subtype of acute myeloid leukemia.
RUNX3 Gene Is First Line Of Defense Against Lung Cancer, Study
RUNX3 is likely to be a key and critical component of the body’s first line of defense against lung cancer development, according to a study.
Bile Duct Cancers Have Country-Specific Characteristics
Scientists have found that bile duct cancers from Singapore, Thailand, and Romania are very different when analyzed at the molecular level.
Researchers ‘Switch On’ Tumor Suppressor Using Non-Coding RNA
Researchers have found that a novel noncoding RNA offers the potential for 'switching on' of tumor suppressors that have been shut off.
Scientists Find Link Between Aristolochic Acid And Liver Cancer
A joint Singapore-Taiwan research has revealed a link between aristolochic acid (AA) and liver cancer.
New Biomarker For Precision Cancer Therapy Identified
A team of scientists have discovered that cancer patients with high levels of the PRL-3 protein may benefit from EGFR-targeting drugs.
Researchers Identify Gene For Aggressive Liver Cancer
Researchers in Singapore have discovered a gene that can be used in the diagnosis and treatment of liver cancer.
A*STAR’s Patrick Tan Wins Chen New Investigator Award
Dr. Patrick Tan from A*STAR's Genome Institute of Singapore has received the 2013 Chen New Investigator Award from the international Human Genome Organization.
